Navigation Links
MicroRNA controls mammary gland development in mice
Date:11/9/2010

This release is available in German.

Hormones, growth factors and several proteins ensure that development occurs in the right way, at the right time. The components that cause breast development in mammals, for example, were thought to be largely known. However, as a team of scientists from Gttingen, Frankfurt and Hanover have now discovered, in the case of breast development, hormones and proteins do not account for the full story. The scientists have shown that tiny ribonucleic acid molecules play a key role in this process. The mammary glands of mice lacking the gene for the microRNAs 212 and 132 failed to grow at puberty. (Nature Genetics, Nov. 7, 2010)

The scientists have demonstrated for the first time in an animal model that small ribonucleic acid molecules, so-called microRNAs, also fulfil an important function in organ development. "This came as a surprise to us," says project leader Kamal Chowdhury from the Max Planck Institute for Biophysical Chemistry in Gttingen. "The mice used in our experiments had all of the hormones, growth factors and proteins that ensure normal breast development. But the absence of the microRNAs miR-212 and miR-132 resulted in the complete failure of duct development in the mammary glands of mice."

It is well known that microRNAs perform very important regulatory functions inside living cells. Although they do not code for proteins, they are responsible for the fine-tuning of the production of certain proteins and intervene extensively in metabolic processes. The question is however: how does this activity shape the morphology of the whole organism? "Using various experiments, we were able to demonstrate that this RNA family plays a key role in mammary gland development and we could locate where these molecules presumably intervene on a regulatory basis," explains Chowdhury.

The mammary gland, which is also known as the milk gland, consists of the milk ducts and the surrounding connective tissue, which has a supportive and regulatory function. The connective tissue also appears to be the location where miR-212 and miR-132 are produced and intervene in the developmental process. Chowdhury and his colleague Ahmet Ucar were able to demonstrate with their experiments that this is the only place where the genes for these ribonucleic acid molecules are "switched on" in the breast tissue.

Molecular dimmer

According to the researcher's model, the microRNA molecules appear to control the production of a protein called MMP-9. "The microRNAs can down-regulate the production of MMP-9, like a dimmer switch," explains Ucar. If the microRNAs are missing, more MMP-9 proteins are produced and they accumulate near the milk ducts. They appear to activate a signalling pathway there, which prevents the normal growth of the milk ducts in the glandular tissue. "These tiny RNA molecules carry out their regulatory function by influencing the communication between the two tissues of the mammary gland," says Ucar. Other experiments now need to be carried out to examine whether these microRNAs also regulate breast development in humans. At the moment, the scientists can only speculate about what happens when the microRNAs do not function correctly. "Whether such malfunctions can lead to the formation of tumours, for example, is something that needs to be examined in further studies," says Chowdhury.


'/>"/>

Contact: Kamal Chowdhury
kchowdh@gwdg.de
Max-Planck-Gesellschaft
Source:Eurekalert  

Related medicine news :

1. Caltech biologists discover microRNAs that control function of blood stem cells
2. MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment
3. Cancer cells show rewired, fragmented microRNA networks
4. Study links microRNA to shut-down of DNA-repair genes
5. Scientists identify microRNA as possible cause of chemotherapy resistance
6. UCLA cancer researchers discover new signaling pathway that controls cell development and cancer
7. FDA accepts historical controls for epilepsy monotherapy studies
8. Scripps Research scientists uncover previously unknown natural mechanism that controls cocaine use
9. TPG Capital Selects MetricStream GRC Platform to Boost its Internal Controls and Compliance
10. Study finds key protein controls T-cell proliferation
11. PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MicroRNA controls mammary gland development in mice
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
Breaking Medicine Technology: